Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

This publication has 32 references indexed in Scilit:

• The prognostic importance of gleason grade in prostatic adenocarcinoma: A long-term follow-up study of 648 patients treated with radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Relationship of tumor DNA-ploidy toserum prostate-specific antigen doubling time after radiotherapy for prostate cancer
  Urology, 1994
• Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate
  Urology, 1993
• Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume
  Cancer, 1993
• Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1992
• The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: The radiation therapy oncology group 75-06 and 77-06 experience
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Pelvic lymphadenectomy for staging clinically localized prostate cancer Indications, Complications, and Results in 217 Cases
  Urology, 1990
• The Incidence of Monotone Likelihood in the Cox Model
  Technometrics, 1981
• Estimation of confidence limits for the cumulative probability of survival in life table analysis
  Journal of Chronic Diseases, 1978